Blood Cancer Journal
This journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders.
Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes
Konstantinos Liapis & Ioannis Kotsianidis, on behalf of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes.
How can we optimally treat patients with hairy cell leukemia (HCL)?
HCL is a rare disease and the therapeutic management could be a suject of discussion. We present here the different options in newly and relapsed/refractory HCL patients.